Archives: Speakers

I partner with entrepreneurs, family offices, and financial sponsors as both a strategic advisor and execution partner — originating and structuring equity, private credit, and M&A transactions. Recent transactions include companies across Aerospace & Defense, Renewable Energy, Infrastructure, Biotechnology, Consumer Packaged Goods, SaaS, and Value-Added Distribution. Drawing on a long-standing network of asset managers, hedge funds, and sponsor platforms, I drive proprietary deal flow and lead end-to-end processes — from initial positioning and investor materials through diligence, negotiation, documentation, and close. My focus is on designing transaction structures that align issuer objectives with investor requirements, while serving as a trusted thought partner to management teams and boards throughout the process. Integrity comes first.

An experienced entrepreneur with broad business knowledge and a deep skill in digital marketing for e-commerce. Has had a wide range of professional experiences from naval nuclear power to launching businesses. Skilled at business development, team building, business operations, and e-commerce conversion strategy.

Federally legal medical cannabis and hemp company backed by Cronos Group (Nasdaq: CRON) and Agroidea.

• Built EU GMP-grade pharmaceutical facility at 1/3 the cost and 1/4 the time of peers.

• Became Colombia’s second-largest cannabis exporter in 2023.

• Achieved lowest cost-per-gram production in Colombia via innovative industrial and process engineering.

• Well positioned to serve the recently rescheduled German medical market and opening EU medicinal markets, with expected U.S. rescheduling as additional catalyst.

Priya Ravisekara, MSc,is a senior analyst at GlobalData in London, UK, where her primary responsibilities include producing analytical reports, improving and maintaining database functionality through quality assurance testing, updating and monitoring Global Data’s Clinical Trials Intelligence Database, and answering queries directly from clients. Priya holds a Masters in Clinical Drug Development from Barts and The London School of Medicine and Dentistry, and a Bachelor of Science in Biochemistry from Brunel University, London.

Marnix van Kruijsdijk is Co-founder and Director of iSprout Finance and Remote, where he focuses on building scalable international delivery models that connect highly skilled South African finance professionals with organisations across Europe. With a background in commercial economics, he brings a strong understanding of business growth, operational efficiency, and market expansion into his work.

Marnix has extensive experience in implementing remote and integrated team models within various accountancy firms, helping organisations address capacity challenges while maintaining quality and consistency.

Through the iSprout x Newtone collaboration, he plays a key role in developing and expanding a high-quality delivery centre in Cape Town, enabling firms to embed dedicated teams into their operations. His focus is on shifting remote collaboration from a temporary solution to a long-term strategic approach. By combining local presence with international talent, Marnix supports firms in building future ready operating models that unlock capacity and create space for higher value advisory work.

Peter Horwich is the Founder and President of Lot 10 LLC, a commercialization partner for MedTech founders translating clinical evidence into real patient impact.

Peter brings 25+ years across the top of MedTech, with senior commercial roles at Johnson & Johnson, Medtronic, and Guidant, plus several startups that went on to acquisition. He has led or contributed to 30+ device launches across cardiac surgery, ECMO, neuromodulation, respiratory, and cardiac rhythm management.

His work sits where clinical strategy meets commercial execution — driven by one conviction: new medical technology only matters when it reaches the patients who need it.

Experienced Research and Innovation Director with a demonstrated history of working in the government, higher education and industry. Skilled in Strategic Development, Public Speaking, Research & Development, Management, Business Innovation, and Project Management. Strong product management professional with a PhD from St Andrews University and a Master of Laws (LLM) focused in Medical Law and Ethics from De Montfort University.

Darren Herger is Feasibility Manager for the Clinical Development Centre (CDC) UK at Novo Nordisk. He leads UK clinical trial feasibility activities across the Novo Nordisk portfolio, liaising with headquarter Trial Allocation teams, UK industry representatives, and UK Investigators. Darren has 25 years of experience in clinical research across multiple roles & therapy areas.